Hirsh, V. (2018). Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: Optimal sequential therapy with EGFR tyrosine kinase inhibitors. Ther Adv Med Oncol.
Stile di citazione ChicagoHirsh, Vera. "Turning EGFR Mutation-positive Non-small-cell Lung cancer Into a Chronic Disease: Optimal Sequential Therapy With EGFR Tyrosine kinase Inhibitors." Ther Adv Med Oncol 2018.
Citazione MLAHirsh, Vera. "Turning EGFR Mutation-positive Non-small-cell Lung cancer Into a Chronic Disease: Optimal Sequential Therapy With EGFR Tyrosine kinase Inhibitors." Ther Adv Med Oncol 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.